USD 0.01
(1.01%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 3.12 Million USD | -35.68% |
2022 | 4.86 Million USD | -28.81% |
2021 | 6.82 Million USD | 51.84% |
2020 | 4.49 Million USD | 720.94% |
2019 | 547.85 Thousand USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 2.87 Million USD | 2.23% |
2024 Q1 | 2.81 Million USD | -9.95% |
2023 Q3 | 3.29 Million USD | -12.7% |
2023 FY | 3.12 Million USD | -35.68% |
2023 Q4 | 3.12 Million USD | -4.97% |
2023 Q2 | 3.76 Million USD | 10.2% |
2023 Q1 | 3.42 Million USD | -29.65% |
2022 Q2 | 11.29 Million USD | -27.98% |
2022 Q1 | 15.68 Million USD | 129.67% |
2022 Q4 | 4.86 Million USD | -40.79% |
2022 FY | 4.86 Million USD | -28.81% |
2022 Q3 | 8.21 Million USD | -27.32% |
2021 FY | 6.82 Million USD | 51.84% |
2021 Q1 | 5.66 Million USD | 26.05% |
2021 Q3 | 5.05 Million USD | 22.72% |
2021 Q4 | 6.82 Million USD | 35.09% |
2021 Q2 | 4.11 Million USD | -27.34% |
2020 Q4 | 4.49 Million USD | 0.0% |
2020 FY | 4.49 Million USD | 720.94% |
2019 FY | 547.85 Thousand USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aclaris Therapeutics, Inc. | - USD | -Infinity% |
Applied DNA Sciences, Inc. | 330.02 Thousand USD | -847.43% |
Aspira Women's Health Inc. | 227 Thousand USD | -1277.434% |
Biodesix, Inc. | 1.4 Million USD | -123.341% |
BioNexus Gene Lab Corp. | 1.13 Million USD | -174.816% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -16816.122% |
bioAffinity Technologies, Inc. | 18.48 Thousand USD | -16816.122% |
Bionano Genomics, Inc. | 22.89 Million USD | 86.342% |
CareDx, Inc | 19.47 Million USD | 83.941% |
Check-Cap Ltd. | - USD | -Infinity% |
Castle Biosciences, Inc. | 7.94 Million USD | 60.63% |
DarioHealth Corp. | 5.06 Million USD | 38.23% |
Exact Sciences Corporation | 127.47 Million USD | 97.547% |
Fulgent Genetics, Inc. | 5.82 Million USD | 46.34% |
Guardant Health, Inc. | 61.94 Million USD | 94.953% |
ICON Public Limited Company | 1.00 USD | -312677500.0% |
IDEXX Laboratories, Inc. | 380.28 Million USD | 99.178% |
Illumina, Inc. | 587 Million USD | 99.467% |
Intelligent Bio Solutions Inc. | 777.53 Thousand USD | -302.139% |
iSpecimen Inc. | - USD | -Infinity% |
Standard BioTools Inc. | 20.53 Million USD | 84.772% |
MDxHealth SA | 2.77 Million USD | -12.514% |
23andMe Holding Co. | 12.46 Million USD | 74.916% |
Medpace Holdings, Inc. | 1.00 USD | -312677500.0% |
Myriad Genetics, Inc. | 20.1 Million USD | 84.444% |
Mainz Biomed B.V. | 613.63 Thousand USD | -409.547% |
ENDRA Life Sciences Inc. | 2.62 Million USD | -19.212% |
NeoGenomics, Inc. | 24.15 Million USD | 87.056% |
Neogen Corporation | 189.26 Million USD | 98.348% |
Inotiv, Inc. | 56.1 Million USD | 94.427% |
Natera, Inc. | 40.75 Million USD | 92.329% |
OpGen, Inc. | 1.00 USD | -312677500.0% |
OPKO Health, Inc. | 65.69 Million USD | 95.241% |
Psychemedics Corporation | 1.00 USD | -312677500.0% |
Prenetics Global Limited | 3.12 Million USD | 0.0% |
Precipio, Inc. | 384 Thousand USD | -714.265% |
Personalis, Inc. | 5.66 Million USD | 44.766% |
RadNet, Inc. | 1.00 USD | -312677500.0% |
Sera Prognostics, Inc. | - USD | -Infinity% |
Sotera Health Company | 51.98 Million USD | 93.985% |
Neuronetics, Inc. | 8.09 Million USD | 61.364% |
Star Equity Holdings, Inc. | 3.42 Million USD | 8.574% |
Star Equity Holdings, Inc. | 3.42 Million USD | 8.574% |
Trinity Biotech plc | 19.93 Million USD | 84.314% |
T2 Biosystems, Inc. | 4.81 Million USD | 35.116% |
Twist Bioscience Corporation | 32.06 Million USD | 90.248% |
Exagen Inc. | 2.87 Million USD | -8.909% |